Alnylam Pharmaceuticals Inc (NAS:ALNY)
$ 265.855 -3.095 (-1.15%) Market Cap: 34.29 Bil Enterprise Value: 33.21 Bil PE Ratio: 0 PB Ratio: 1,063.42 GF Score: 78/100

Alnylam Pharmaceuticals Inc at H C Wainwright Global Investment Conference (Virtual) Transcript

Sep 13, 2021 / 11:00AM GMT
Release Date Price: $185.79 (-1.98%)
Patrick Ralph Trucchio
H.C. Wainwright & Co, LLC, Research Division - MD of Equity Research & Senior Healthcare Analyst

Hello, everyone, and thank you for joining H.C. Wainwright 23rd Annual Global Investment Conference. My name is Patrick Trucchio, and I'm a Senior Biotech Analyst at H.C. Wainwright. Although we are virtual this year, we are confident we're going to be able to provide value to you with more than 850 companies presenting at this conference as well as through your interactions during one-on-one meetings.

H.C. Wainwright is a full-service investment bank dedicated to providing corporate finance strategic advisory and related services to public and private companies across multiple sectors and regions. We have a total of 19 senior publishing analysts and over 560 companies covered across all sectors. Please visit hcwco.com for more information.

From a logistics standpoint, please make sure to reference your virtual conference online portal that provides your individual links to your meetings and all presentations. Please join us for corporate presentations and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot